Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MELISSA HART

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1710504691
CMS profile
10566718
Location
BOULDER CITY, NV

General Payments · PY2021–2024

$1,854.32

  • Reported across 56 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$406.30

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $306.31 15
Education $99.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $136.02 2
Novo Nordisk AS $115.05 6
ABBVIE INC. $78.63 4
Lilly USA, LLC $38.36 2
Otsuka America Pharmaceutical, Inc. $22.86 1
Acerta Pharma LLC $15.38 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $983.53 11
PY2022 $255.21 19
PY2023 $209.28 10
PY2024 $406.30 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.53 01/24/2024 Food and Beverage Undisputed 01/23/2026 1107298490 CMS
ABBVIE INC. $15.82 03/14/2024 Food and Beverage Undisputed 01/23/2026 1107298492 CMS
ABBVIE INC. $18.54 04/02/2024 Food and Beverage Undisputed 01/23/2026 1107298494 CMS
ABBVIE INC. $26.74 05/16/2024 Food and Beverage Undisputed 01/23/2026 1107298496 CMS
Astellas Pharma US Inc $36.03 02/01/2024 Food and Beverage Undisputed 01/23/2026 1139525118 CMS
Astellas Pharma US Inc $99.99 03/06/2024 Education Undisputed 01/23/2026 1139505363 CMS
AstraZeneca Pharmaceuticals LP $15.38 09/20/2024 Food and Beverage Undisputed 01/23/2026 1104749812 CMS
Lilly USA, LLC $14.86 05/30/2024 Food and Beverage Undisputed 01/23/2026 1135745624 CMS
Lilly USA, LLC $23.50 11/04/2024 Food and Beverage Undisputed 01/23/2026 1135829301 CMS
Novo Nordisk Inc $15.49 01/04/2024 Food and Beverage Undisputed 01/23/2026 1100512441 CMS
Novo Nordisk Inc $17.71 03/28/2024 Food and Beverage Undisputed 01/23/2026 1100234582 CMS
Novo Nordisk Inc $23.74 04/25/2024 Food and Beverage Undisputed 01/23/2026 1100354896 CMS
Novo Nordisk Inc $23.03 08/15/2024 Food and Beverage Undisputed 01/23/2026 1100287056 CMS
Novo Nordisk Inc $13.47 10/30/2024 Food and Beverage Undisputed 01/23/2026 1100269596 CMS
Novo Nordisk Inc $21.61 11/07/2024 Food and Beverage Undisputed 01/23/2026 1100338123 CMS
Otsuka America Pharmaceutical, Inc. $22.86 04/20/2024 Food and Beverage Undisputed 01/23/2026 1119089876 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.